Americans have conflicting views on how technologies that allow human genome editing, such as one that uses the Cas9 enzyme to snip DNA, should be employed. Meletios/shutterstock
CRISPR, the powerful genome-editing tool, does a molecular tango to cut and modify DNA that is highly nuanced. The same subtlety applies to the public’s…
Comments closed
The European Patent Office has signaled that it intends to grant MilliporeSigma a key CRISPR patent. vchal/shutterstock
MilliporeSigma, a subsidiary of pharmaceutical giant Merck KGaA of Darmstadt, Germany, has become a new major player in the complicated European patent battles over CRISPR,…
Comments closedPARIS—An HIV-infected child in South Africa who is controlling the virus without antiretroviral (ARV) drugs has reinvigorated the push to find ways to allow people…
Comments closed
The University of California (UC) has fired another legal salvo in the prolonged patent battle over CRISPR, the revolutionary gene-editing technology that has spawned a…
Comments closed
The rate of new HIV/AIDS infections has plummeted in hard-hit Swaziland, showing the power of treatment as prevention. JON HRUSA/EPA/Redux
PARIS—New data from Swaziland, a tiny country in southern Africa, provide some of the most convincing evidence yet that aggressively ramping up treatment for HIV/AIDS…
Comments closed
Photo: Jon Cohen
A new update on the global HIV/AIDS epidemic offers “scorecards” for countries that starkly highlight successes in green and failures in red (for an example,…
Comments closed
Dr. Lukas Wartman, a physician and researcher at Washington University School of Medicine in St. Louis, puts in eyedrops as he works from home on Tuesday, June 6, 2017, in St. Louis. Wartman was diagnosed with acute lymphoblastic leukemia in 2003 during his last year of medical school. His recovery has been complicated by graft-versus-host disease (GVHD) from stem cell transplants, where the donor's immune system attacks the recipient's body because it sees it as foreign. Photo: Whitney Curtis
ST. LOUIS, MISSOURI—A few months before completing medical school in 2003, Lukas Wartman was diagnosed with acute lymphoblastic leukemia (ALL), a blood cancer that’s particularly…
Comments closed
A hospital worker in Conakry in 2015 opted to receive the experimental VSV Ebola vaccine. Idrissa SOUMARE/Afreecom
As health officials and aid workers head to a remote corner of the Democratic Republic of the Congo to respond to an outbreak of Ebola…
Comments closed
As health officials and aid workers head to a remote corner of the Democratic Republic of the Congo to respond to an outbreak of Ebola…
Comments closed